401(k) Plans Defined Benefit (DB) Plans Defined Contribution (DC) Plans Employee Benefits Retirement U.S.

2023 Employee Benefits Reporting and Disclosure Calendars

Jenny Gartman, CEBS1 Comment

Plan sponsors and administrators are encouraged to reference these comprehensive calendars to stay on track in 2023.

Health and Retirement Plans Subject to ERISA (Includes Multiemployer Plans)

Health and Welfare Plans

New deadlines in 2023 are:

  • Prescription Drug Data Collection (RxDC) for 2020 and 2021 data has been extended to January 31, 2023.
  • Reporting for 2022 data is due June 1, 2023.

Retirement Plans

Defined Contribution

Defined Benefit

If you thought this information was helpful, and you’re an International Foundation or ISCEBS member, be sure to check out InfoQuick. This content came from General Benefits: Reporting & Disclosure Calendars, but there are tons of topics to choose from and the information will be delivered instantly via email. Available exclusively to members at no cost!

Jenny Gartman, CEBS

Manager, Reference/Research Services at the International Foundation

Favorite Foundation Member Service: Personalized Research Service

Benefits Topics That Interest Her Most: Mental health and retirement security

Personal Insight: Jenny likes spending time with family, knitting, reading memoirs and going for walks around the neighborhood.

1 Comment

  1. Melissa Zaino

    This is an excellent resource – thank you for providing it.

Comments are closed.

Recommended Posts

Open pharmacy pill containers on a pile of 20 dollar bills.
Compliance DOL Employee Benefits ERISA Health Care Legislative Prescription Drugs U.S.

What the Executive Order Increasing PBM Fee Transparency Means for Employers
Amanda Wilke, CEBS
 

On April 15, 2025, President Trump signed the executive order (EO) “Lowering Drug Prices by Once Again Putting Americans First,” which includes specific actions to be taken by federal agencies to reduce prescription drug costs, improve transparency and increase competition in the […]

Continue Reading....
Canada Employee Benefits Health Care Prescription Drugs

GLP-1 Drug Coverage Continues to Rise in Canada 
Rebecca Plier
 

New Survey Data Reveals Prior Authorization or Other Utilization Management Strategies, Eligibility Requirements, Annual Maximum as Leading Cost Control Methods  A new survey report from the International Foundation of Employee Benefit Plans reveals updated Canadian employer coverage and cost-control mechanisms surrounding glucagon-like […]

Continue Reading....
Disease Management Employee Benefits Health Care Prescription Drugs U.S.

GLP-1 Drugs Responsible for Over Ten Percent of Annual Claims 
Rebecca Plier
 

New Survey Data Reveals Rise of GLP-1 Drug Claims, With Utilization Management and Eligibility Requirements as Leading Cost-Control Mechanisms   A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage and claims representation surrounding glucagon-like peptide-1 […]

Continue Reading....